Morgan Stanley Ups Shire to 'Overweight'

Analyst Marc Goodman says he's more bullish, as he favors the drug maker's business model in the current environment

Morgan Stanley upgraded Shire Pharmaceutical (SHPGY ) to overweight from equal-weight.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.